Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Jan Beumer, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00446004
First received: March 8, 2007
Last updated: June 21, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)